Tag: GALT

Blue Horseshoe Stocks: DLTR Recap & More

Dollar Tree, Inc. DLTR – Options Update

Yesterday turned out to be a nice bullish session for DLTR, making us glad we added it as a focus in our premarket report. No sooner than we updated our readers on the DLTR options ideas we submitted in last Wednesday‘s premarket report, did they take off to new highs once again.

The DLTR 04/21 $78-80 Calls had already provided us with double-bag gain chances, but yesterday’s activity pushed those figures a lot higher. The following numbers represent the maximum possible gains so far over the last six trading sessions:

$78 Calls – Range: .51-2.05 – Max Gain: 301%
$78.50 Calls – Range: .63-2.05 – Max Gain: 225%
$79 Calls – Range:  .48-1.43 – Max Gain: 198%
$79.50 Calls – Range: .35-1.40- Max Gain: 300%
$80 Calls – Range: .30-1.34 – Max Gain: 347%

We can continue to keep these contracts on our radar, with more than three weeks remaining until their expiration date.

Petroleo Brasiliero S.A. (Petrobras) PBR – Update

Another set of 04/21 options contracts that we’ve been tracking have also fared well, tacking on new highs yesterday,

We slated the PBR 04/21 $9.50 & $10 Calls for observation a week ago today, and must now swing back around to highlight the excellent moves these plays have made in a week’s time.

04/21 $9.50 Calls – Range: .18-.51 – Max Gain: 183%
04/21 $10 Calls – Range: .09-.27 – Max Gain: 200%

As stated on the above mentioned play, these contracts have more than three weeks before expiration, so we’ll continue to keep tracking their activity in coming sessions. Yesterday the stock closed just under the 200DMA of 9.69, and we’ll remain bullish on these ideas if the stock can break past that barrier.

Sphere 3D Corp. ANY

We want to make mention of ANY this morning after noticing a set of interesting circumstances. Just a few days following the closing of a $4.5M direct offering/ private placement, the company has now announced it has been awarded a $3M contract  (>>View PR)

All of this activity on the newsreel is happening concurrently with a potential reversal and rebound on the chart. The stock has been failing to satisfy its $1.00 minimum bid requirement for the better part of nine months now, and will need to get itself back above that mark or it could face delisting after just three years on the NASDAQ.

Extended Watchlist:
USRM, MMEX, DOLV, MYDX, GALT, EMKR, BCEI, VNCE,

Blue Horseshoe Stocks: Several Key Updates

Intercloud Systems, Inc. ICLD

In yesterday’s report kicking off the new trading week, we backtracked to our alert of ICLD coming in our report from two Thursday’s ago, at which time the stock was trading at a low of .0157.

We mentioned how it had risen exponentially since that report, and specifically cautioned our readers to track its movements closely right from yesterday’s opening bell. The strength of the ICLD close on Friday was simply too strong to ignore and despite already having spiked considerably for us up to that point, the stock turned in another fantastic intraday performance.

From an early low of .05, the stock ran all the way to .0869 during the course of a session where it steadily climbed all day long and closed near its high. That marked an intraday boost of 74% and and an overall move up of 340% from our observed low from Thursday the 2nd,

Once again, with the intensely bullish close to another session, we’re going to have our eyes peeled for further moves from ICLD, whether they come in the form of a continued push upward, or are preceded by a dip-and-rip pattern off of these impressive highs.

Ciber, Inc. CBR

Prior to yesterday, CBR had been stuck in a rut for quite some time, but we noticed some abnormal premarket activity and decided to include it in yesterday’s report. It was a good idea, with CBR running from .4329 to .65, which works out to a 50% intraday pop.

The move came in conjunction with the company announcement that it was mulling over an unsolicited offer to be acquired through merger by Ameri Holdings, Inc. (AMRH) which values it at .75/share of CBR stock.

Given that the stock is still trading in the low .60’s at present, we’ll be interested to continue to monitor its progress as the company deliberates the merger offer.

More Key Updates

Cerulean Pharmaceuticals, Inc. CERU – We began tracking CERU just over a month ago, and after an extended period of slow and steady increases, finally yesterday the stock broke out in a more significant manner.

Our initial alert on CERU came on the 3rd of February, at which time the stock was trading at a low of 1.11. Yesterday the stock streaked to an impressive new high of 2.65, which comes out to a total upswing of 139%

______

Aurinia Pharmaceuticals, Inc. AUPH –  AUPH is another stock we’ve been tracking for much of 2017 so far that also broke to new highs yesterday. We witnessed a low of 2.95 in AUPH subsequent to our alert on the stock dated January 27th. Gradual increases over the next month would occur, and since we’ve hit the month of March, the stock has been going haywire.

Yesterday AUPH soared to (and closed at) 10.54 which represents a total move of 257% in less than six weeks!

Fresh Options Idea
Direxion Daily Jr Gld Mnrs Bull 3X ETF  – JNUG 03/31 $7-8 Calls

Extended Watchlist:
MGI, CPRX, GALT, EARS, RNN

Blue Horseshoe Stocks: BURL Recap & More

Burlington Stores, Inc. BURL – Options Update

Our first order of business this morning will be to go back to the options idea we signaled for the BURL chain on Thursday morning, the BURL 03/17 $85-95 Calls. We reported the solid gains that the strong earnings report allowed us on that first day in Friday’s morning report, and today we’ll have to follow up once again to relay the added opportunities we saw to close out the week.

We did caution on Friday that based on premarket activity, our ranges could be extended considerably, and that’s exactly what happened. The updates ranges showing the total moves we seen over a two session span are as follows:

$85 Calls – Range: 5.60-11.13 – Max Gain: 99%
$90 Calls – Range: 2.50-7.35 – Max Gain: 194%
$95 Calls – Range: .71-3.50 – Max Gain: 392%

Galectin Therapeutics, Inc. GALT

GALT is a stock that we began tracking earlier in 2017, including it in our report on January 17th. Shortly following that alert, the stock saw a low of .935 and it hasn’t looked back since.

We followed up with an update of GALT on February 10th, at which time we had seen a relatively modest range of .935 to 1.29 (+38%). We noted that the gains would be “sustainable if GALT can manage to crack past the current 200DMA” (then at 1.32).

That did happen, and on the 15th we posted another followup stating “One more bullish push will get us into double-bagger territory for this idea, and the stock may well make a run into the 2.00-range.” Our assumptions proved spot-on again, as one week later, the stock went on to hit a high of 2.21, representing a total move up from our observed low of .935 amounting to 136%

Once again GALT is heading to highs, this morning trading as high as 2.30 in the premarket on the heels of some positive clinical trial data (>>View PR). We’re going to want to be paying attention to its activity as we open up another trading week, as expectations of extended gains once again do not seem unreasonable.

Extended Watchlist:
RNVA, CXRX, PTCT, CCTL, CXRX, PIP